Transdermal immunization: biological framework and translational perspectives

Bibliography

• Hilleman MR. Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. Vaccine 2000;18:1436-47
   PubMed Web of Science ®Google Scholar
• Jacobson MR, Swan A, Adegbenro A, Making vaccines more acceptable-methods to prevent and minimize pain and other common adverse events associated with vaccines. Vaccine 2001;19:2418-27
   PubMed Web of Science ®Google Scholar
• Levine MM. Ideal vaccines for resource poor settings. Vaccine 2011;29S:D116-25
   Google Scholar
• Correia-Pinto JF, Csaba N, Alonso MJ. Vaccine delivery carriers: insights and future perspectives. Int J Pharm 2012; [Epub ahead of print]
   PubMedGoogle Scholar
• Melgaard B. Immunization in the 21st century- the way forward. Acta Trop 2001;80:119-24
   PubMed Web of Science ®Google Scholar
• Jodar L, Duclos P, Milstien JB, Ensuring vaccine safety in immunization programmes – a WHO perspective. Vaccine 2001;19:1594-05
   PubMed Web of Science ®Google Scholar
• O'Hagan DT, Rappuoli R. Novel approaches to pediatric vaccine delivery. Adv Drug Deliv Rev 2006;58:29-51
   PubMed Web of Science ®Google Scholar
• Glenn GM, Rao M, Matyas GR, Skin immunization made possible by cholera toxin. Nature 1998;391:851
   PubMed Web of Science ®Google Scholar
• Giudice EL, Campbell JD. Needle free vaccine delivery. Adv Drug Deliv Rev 2006;58:68-89
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56:603-18
   PubMed Web of Science ®Google Scholar
• Bal SM, Ding Z, van Riet E, Advances in transcutaneous vaccine delivery: do all ways lead to Rome? J Control Release 2010;148:266-82
   PubMed Web of Science ®Google Scholar
• Li N, Peng LH, Chen X, Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers. Vaccine 2011;29:6179-90
   PubMed Web of Science ®Google Scholar
• Bos JD, Kapsenberg ML. The skin immune system: progress in cutaneous biology. Immunol Today 1993;14(2):75-8
   PubMedGoogle Scholar
• Bhargava A, Mishra D, Banerjee S, Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation. Immunotherapy 2012;4(7):703-18
   PubMed Web of Science ®Google Scholar
• Nestle FO, Di Meglio P, Qin JZ, Skin immune sentinels in health and disease. Nat Rev Immunol 2009;9(10):679-91
   PubMed Web of Science ®Google Scholar
• Igyarto BZ, Haley K, Ortner D, Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 2011;35(2):260-72
   PubMed Web of Science ®Google Scholar
• Dupasquier M, Prens EP, Leenen PJM. Dermal mononuclear phagocytes. In: Saeland S, editor. Recent advances in skin immunology. Research Signpost; Trivandrum, Kerala, India; 2008. p. 75-104
   Google Scholar
• Romani N, Flacher V, Tripp CH, Targeting skin dendritic cells to improve intradermal vaccination. Curr Top Microbiol Immunol 2012;351:113-38
   PubMed Web of Science ®Google Scholar
• Johnson-Huang LM, McNutt NS, Krueger JG, Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases. J Clin Immunol 2009;29(3):247-56
   PubMed Web of Science ®Google Scholar
• Curry JL, Qin JZ, Bonish B, Innate immune-related receptors in normal and psoriatic skin. Arch Pathol Lab Med 2003;127(2):178-86
   PubMed Web of Science ®Google Scholar
• Ochoa MT, Loncaric A, Krutzik SR, "Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages. J Invest Dermatol 2008;128(9):2225-31
   PubMed Web of Science ®Google Scholar
• Rozis G, Benlahrech A, Duraisingham S, Human langerhans' cells and dermal-type dendritic cells generated from CD34 stem cells express different toll-like receptors and secrete different cytokines in response to toll-like receptor ligands. Immunology 2008;124(3):329-38
   PubMed Web of Science ®Google Scholar
• Dubsky P, Ueno H, Piqueras B, Human dendritic cell subsets for vaccination. J Clin Immunol 2005;25(6):551-72
   PubMed Web of Science ®Google Scholar
• Banchereau J, Briere F, Caux C, Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811
   PubMed Web of Science ®Google Scholar
• Le Borgne M, Dubois B, Kaiserlian D. Dendritic cells of mucosa and skin: "recruited for vaccination". Med Sci 2007;23(10):819-25
   Google Scholar
• Steinman RM, Idoyaga J. Features of the dendritic cell lineage. Immunol Rev 2010;234(1):5-17
   PubMedGoogle Scholar
• Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 2000;1:199-05
   PubMed Web of Science ®Google Scholar
• Biedermann T, Rocken M, Carballido JM. TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J Invest Dermatol Symp Proc 2004;9(1):5-14
   PubMed Web of Science ®Google Scholar
• Sokolovska A, Hem SL, HogenEsch H. Activation of dendritic cells and induction of CD4+ T cell differentiation by aluminum-containing adjuvants. Vaccine 2007;25:4575-85
   PubMed Web of Science ®Google Scholar
• Zhou W, Peng Q, Li K, Role of dendritic cell synthesis of complement in the allospecific T cell response. Mol Immunol 2007;44:57-63
   PubMed Web of Science ®Google Scholar
• Tacken PJ, Torensma R, Figdor CG. Targeting antigens to dendritic cells in vivo. Immunobiology 2006;211:599-08
   PubMed Web of Science ®Google Scholar
• Glenn GM, Scharton-Kersten T, Alving CR. Advances in vaccine delivery: transcutaneous immunization. Expert Opin Invest Drugs 1999;8(6):797-05
   PubMedGoogle Scholar
• Scharton-Kersten T, Glenn GM, Vassell R, Principles of transcutaneous immunization using cholera toxin as an adjuvant. Vaccine 1999;17:S37-43
   PubMed Web of Science ®Google Scholar
• Peachman KK, Mclean DM, Tong JC, Ganglioside GM1 binding peptides: a potential adjuvant for transcutaneous immunization. Open Immunol J 2009;2:94-102
   Google Scholar
• Warger T, Schild H, Rechtsteiner G. Initiation of adaptive immune responses by transcutaneous immunization. Immunol Lett 2007;109:13-20
   PubMed Web of Science ®Google Scholar
• Hammond SA, Tsonis C, Sellins K, Transcutaneous immunization of domestic animals: opportunities and challenges. Adv Drug Deliv Rev 2000;43:45-55
   PubMed Web of Science ®Google Scholar
• Glenn GM, Scharton-Kersten T, Vassell R, Transcutaneous immunization using bacaterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect Immun 1999;67:1100-6
   PubMed Web of Science ®Google Scholar
• Foged C, Arigita C, Sundblad A, Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. Vaccine 2004;22:1903-13
   PubMed Web of Science ®Google Scholar
• Paul A, Cevc G, Bachhawat BK. Transdermal immunization with large proteins by means of ultradeformable drug carriers. Vaccine 1998;16(2/3):188-95
   PubMedGoogle Scholar
• Babiuk S, Baca-Estrada M, Babiuk LA, Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J Control Release 2000;66:199-214
   PubMed Web of Science ®Google Scholar
• Glenn GM, Taylor DN, Li XR, Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med 2000;6:1403-6
   PubMed Web of Science ®Google Scholar
• Gaspari AA, Jenkins MR, Katz SI. Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes. J Immunol 1991;147:4155-61
   PubMed Web of Science ®Google Scholar
• Bos JD. editor. Skin immune system. CRC Press, USA; 1990. p. 57-87; 257-91
   Google Scholar
• Shahiwala A, Vyas TK, Amiji MM. Nanocarriers for systemic and mucosal vaccine delivery. Recent Pat Drug Deliv Formul 2007;1:1-9
   PubMedGoogle Scholar
• Karande P, Arora A, Pham TK, Transcutaneous immunization using common chemicals. J Control Release 2009;138:134-40
   PubMed Web of Science ®Google Scholar
• Peachman KK, Rao M, Alving CR. Immunization with DNA through the skin. Methods 2003;31:232-42
   PubMed Web of Science ®Google Scholar
• Mumper RJ, Cui Z. Genetic immunization by jet injection of targeted pDNA-coated nanoparticles. Methods 2003;31:255-62
   PubMed Web of Science ®Google Scholar
• Rao SS, Gomez P, Mascola JR, Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model. Vaccine 2006;24:367-73
   PubMed Web of Science ®Google Scholar
• Banga AK, Prausnitz MR. Assessing the potential of skin electroporation for the delivery of protein and gene based drugs. Trends Biotechnol 1998;16(10):408-12
   PubMed Web of Science ®Google Scholar
• Medi BM, Hoselton S, Marepalli RB, Skin targeted DNA vaccine delivery using electroporation in rabbits I: efficacy. Int J Pharm 2005;294:53-63
   PubMed Web of Science ®Google Scholar
• Zhao YL, Murthy SN, Manjili MH, Induction of cytotoxic T-lymphocytes by electroporation enhanced needle-free skin immunization. Vaccine 2006;24:1282-90
   PubMed Web of Science ®Google Scholar
• Schuetz YB, Schuetza B, Carrupt P, Structure–permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis. Eur J Pharm Sci 2006;29:53-9
   PubMed Web of Science ®Google Scholar
• Oldenburg KR, Vo KT, Smith GA, Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin. J Pharm Sci 1995;84:915-21
   PubMed Web of Science ®Google Scholar
• Mitragotri S, Edwards DA, Blankschtein D, A mechanistic study of ultrasonically enhanced transdermal drug delivery. J Pharm Sci 1995;84:697-06
   PubMed Web of Science ®Google Scholar
• Tezel A, Paliwal S, Shen Z, Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine 2005;23:3800-7
   PubMed Web of Science ®Google Scholar
• Ogura M, Paliwal S, Mitragotri S. Low frequency sonophoresis: current status and future prospects. Adv Drug Deliv Rev 2008;60:1218-23
   PubMed Web of Science ®Google Scholar
• Lee S, McAuliffe DJ, Flotte TJ, Photomechanical transcutaneous delivery of macromolecules. J Invest Dermatol 1998;111:925-9
   PubMed Web of Science ®Google Scholar
• Cross SE, Roberts MS. Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr Drug Deliv 2004;1(1):81-92
   PubMedGoogle Scholar
• Park J, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 2005;104:51-66
   PubMed Web of Science ®Google Scholar
• van der Maaden K, Jiskoot W, Bouwstra J. Microneedle technologies for transdermal drug and vaccine delivery. J Control Release 2012;161:645-55
   PubMed Web of Science ®Google Scholar
• Andrianov AK, Mutwiri G. Intradermal immunization using coated microneedles containing an immunoadjuvant. Vaccine 2012;30:4355-60
   PubMed Web of Science ®Google Scholar
• Chen D, Erickson CA, Endres RL, Adjuvantation of epidermal powder immunization. Vaccine 2001;19:2908-17
   PubMed Web of Science ®Google Scholar
• Dean HJ, Fuller D, Osorio JE. Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis. Comp Immunol Microbiol Infect Dis 2003;26:373-88
   PubMed Web of Science ®Google Scholar
• Wischke C, Borchert H, Zimmermann J, Stable cationic microparticles for enhanced model antigen delivery to dendritic cells. J Control Release 2006;114:359-68
   PubMed Web of Science ®Google Scholar
• Christine-Lutsiak ME, Robinson DR, Coester C, Analysis of poly (d, l-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Pharm Res 2002;19(10):1480-7
   PubMed Web of Science ®Google Scholar
• Saraf S, Mishra D, Asthana A, Lipid microparticles for mucosal immunization against hepatitis B. Vaccine 2006;24:45-56
   PubMed Web of Science ®Google Scholar
• Mishra H, Mishra D, Mishra PK, Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis B surface antigen for vaccination using subcutaneous route. J Pharm Pharm Sci 2010;13(4):495-09
   PubMed Web of Science ®Google Scholar
• Kohli AK, Alpar HO. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharm 2004;275:13-17
   PubMed Web of Science ®Google Scholar
• Zasadzinski JA, Wong B, Forbes N, Novel methods of enhanced retention in and rapid, targeted release from liposomes. Curr Opin Colloid Interface Sci 2011;16:203-14
   PubMed Web of Science ®Google Scholar
• Shahiwala A, Vyas TK, Amiji MM. Nanocarriers for systemic and mucosal vaccine delivery. Recent Pat Drug Deliv Formul 2007;1:1-9
   PubMedGoogle Scholar
• Dubey V, Mishra D, Asthana A, Transdermal delivery of a pineal hormone melatonin via elastic liposomes. Biomaterials 2006;27:3491-6
   PubMed Web of Science ®Google Scholar
• Mishra D, Garg M, Dubey V, Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J Pharm Sci 2007;96:145-55
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992;1104:226-32
   PubMed Web of Science ®Google Scholar
• Cevc G. Lipid suspensions on the skin. Penetration enhancement, vesicle penetration and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 1996;13:257-88
   PubMed Web of Science ®Google Scholar
• Mishra D, Dubey V, Asthana A, Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine 2006;24:4847-55
   PubMed Web of Science ®Google Scholar
• Mishra D, Mishra PK, Dubey V, Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with Hepatitis B surface antigen loaded elastic liposomes. Vaccine 2007;25(39–40):6939-44
   PubMed Web of Science ®Google Scholar
• Elsayed MMA, Abdallah OY, Naggar VF, Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 2007;332:1-16
   PubMed Web of Science ®Google Scholar
• Dubey V, Mishra D, Nahar M, Vesicles as tools for the modulation of skin permeability. Expert Opin Drug Deliv 2007;4(6):579-93
   PubMed Web of Science ®Google Scholar
• Touitou E, Alkabes M, Dayan N. Ethosomes: novel lipid vesicular system for enhanced delivery. Pharm Res 1997;S14:305-6
   Google Scholar
• Touitou E, Dayan N, Bergelson L, Ethosomes- novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000;65:403-18
   PubMed Web of Science ®Google Scholar
• Fynan EF, Webster RG, Fuller DH, DNA vaccines: protective immunizations by parenteral, mucosal, and gene gun inoculations. Proc Natl Acad Sci USA 1993;90(24):11478-82
   PubMed Web of Science ®Google Scholar
• Zarozinski CC, Fynan EF, Selin LK, Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J Immunol 1995;154:4010-17
   PubMed Web of Science ®Google Scholar
• Regnier V, Preat V. Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation. Pharm Res 1998;15(10):1596-02
   PubMed Web of Science ®Google Scholar
• Mishra A, Ganga S, Upadhyay P. Needle-free, non-adjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus. Vaccine 1999;18(5-6):517-23
   PubMed Web of Science ®Google Scholar
• Shi Z, Zeng M, Yang G, Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines. J Virol 2001;75(23):11474-82
   PubMed Web of Science ®Google Scholar
• Heckert RA, Elankumaran S. Topical DNA immunization with DMSO. Vet Immunol Immunopathol 2002;89:67-81
   PubMed Web of Science ®Google Scholar
• Bramson J, Dayball K, Evelegh C, Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther 2003;10(3):251-60
   PubMed Web of Science ®Google Scholar
• Matyas GR, Friedlander AM, Glenn GM, Needle-free skin patch vaccination method for anthrax. Infect Immun 2004;72(2):1181-3
   PubMed Web of Science ®Google Scholar
• Upadhyay P. Enhanced transdermal-immunization with diptheria-toxoid using local hyperthermia. Vaccine 2006;24:5593-8
   PubMed Web of Science ®Google Scholar
• Glenn GM, Flyer DC, Ellingsworth LR, Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch. Expert Rev Vaccines 2007;6(5):809-19
   PubMed Web of Science ®Google Scholar
• Vogt A, Mahe B, Costagliola D, Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J Immunol 2008;180(3):1482-9
   PubMed Web of Science ®Google Scholar
• Mishra D, Mishra PK, Dubey V, Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes. Eur J Pharm Sci 2008;33:424-33
   PubMed Web of Science ®Google Scholar
• Kim YC, Yuan FS, Yoo DG, Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine 2009;27:6932-8
   PubMed Web of Science ®Google Scholar
• Combadiere B, Vogt A, Mahe B, Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One 2010;5(5):e10818
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Yoo DG, Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis 2010;201(2):190-8
   PubMed Web of Science ®Google Scholar
• Matsuo K, Ishii Y, Quan YS, Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat. J Control Release 2011;149(1):15-20
   PubMed Web of Science ®Google Scholar
• Ding Z, Bal SM, Romeijn S, Transcutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle array. Pharm Res 2011;28(1):145-58
   PubMed Web of Science ®Google Scholar
• Bal SM, Slutter B, Jiskoot W, Small is beautiful: N-trimethyl chitosan–ovalbumin conjugates for microneedle-based transcutaneous immunization. Vaccine 2011;29:4025-32
   PubMed Web of Science ®Google Scholar
• Hirobe S, Matsuo K, Quan YS, Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria. Vaccine 2012;30:1847-54
   PubMed Web of Science ®Google Scholar
• Anto V, Marie GM, John BC, Coated microneedle arrays for transcutaneous delivery of live virus vaccines. J Control Release 2012;159:34-42
   PubMed Web of Science ®Google Scholar